Bayer Reinforces R&D Despite Economic Turmoil...

Bayer intends to expand its R&D activities further, despite the financial and economic crisis, chairman and CEO Werner Wenning says. Bayer’s €2.8-billion ($3.7 billion) R&D budget this year is the biggest R&D budget in Germany’s chemical and pharmaceutical sector and accounts for about 5% of all R&D spending by German industry as a whole, Wenning told journalists at the company’s “Perspective on Innovation 2008” meeting, held recently in Leverkusen. Bayer’s pharma pipeline has 50 projects in phases I to III...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers